DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erbitux (Cetuximab) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (89)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erbitux (Cetuximab) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 89   Next >>

Possible Erbitux side effects in male

Reported by a physician from France on 2012-08-16

Patient: male

Reactions: Anaphylactic Shock, Headache, Hyperhidrosis, Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 816mg single dose
    Indication: Tonsil Cancer
    Start date: 2012-07-24
    End date: 2012-07-24

Zofran
    Dosage: 8mg single dose
    Indication: Nausea
    Start date: 2012-07-24
    End date: 2012-07-24

Other drugs received by patient: Solu-Medrol; Polaramine



Possible Erbitux side effects in 76 year old male

Reported by a consumer/non-health professional from Germany on 2012-08-10

Patient: 76 year old male

Reactions: Confusional State, Transient Ischaemic Attack, Loss of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Irinotecan HCL



Possible Erbitux side effects in male

Reported by a pharmacist from United States on 2012-08-10

Patient: male

Reactions: Chest Discomfort, Nausea, Chills, Erythema, Chest Pain, Feeling Hot, Dizziness, Infusion Related Reaction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 51 year old female

Reported by a physician from Germany on 2012-07-30

Patient: 51 year old female, weighing 54.0 kg (118.8 pounds)

Reactions: Endocarditis, Device Related Infection, Cardiac Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 66 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-27

Patient: 66 year old male, weighing 64.0 kg (140.8 pounds)

Reactions: Mucosal Inflammation, Pneumonia Aspiration, Dysphagia, Pain, Toxic Epidermal Necrolysis, General Physical Health Deterioration, Rash Maculo-Papular, Stevens-Johnson Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Perenterol; Novasource; Remeron; Aldactone; Concor; Levothyroxine Sodium; Nexium; Dipiperon; Fragmin; Cordarone; Zestril



Possible Erbitux side effects in 63 year old male

Reported by a physician from Germany on 2012-07-27

Patient: 63 year old male

Reactions: Electrocardiogram Abnormal, Acute Myocardial Infarction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Leucovorin Calcium
    Indication: Colon Cancer
    Start date: 2012-06-19

Fluorouracil
    Indication: Colon Cancer
    Start date: 2012-06-19

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2012-06-19

Erbitux
    Indication: Colon Cancer
    Start date: 2012-06-19

Other drugs received by patient: Quinine Sulfate; Omeprazole; Zopiclone; Lyrica; Mobic



Possible Erbitux side effects in 62 year old male

Reported by a consumer/non-health professional from Japan on 2012-07-25

Patient: 62 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Neutropenia, Idiopathic Thrombocytopenic Purpura, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-01-31
    End date: 2012-01-31

Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-02-07
    End date: 2012-02-07

Irinotecan Hydrochloride
    Dosage: 200 mg, 1x/day
    Indication: Colon Cancer
    Start date: 2012-01-17
    End date: 2012-01-17

Erbitux
    Dosage: 600 mg, 1x/day
    Indication: Colon Cancer
    Start date: 2012-01-17
    End date: 2012-01-17

Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-02-14
    End date: 2012-02-14

Irinotecan Hydrochloride
    Dosage: 200 mg, 1x/day
    Start date: 2012-02-14
    End date: 2012-02-14

Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-01-24
    End date: 2012-01-24

Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-02-21
    End date: 2012-02-21

Irinotecan Hydrochloride
    Dosage: 200 mg, 1x/day
    Start date: 2012-01-31
    End date: 2012-01-31

Other drugs received by patient: Globulin N; Platelets, Human Blood; Decadron; Prednisolone; Famotidine; Promacta; Esomeprazole Magnesium; Amoxicillin; Clarithromycin



Possible Erbitux side effects in 62 year old male

Reported by a consumer/non-health professional from Japan on 2012-07-23

Patient: 62 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Neutropenia, Idiopathic Thrombocytopenic Purpura, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-01-24
    End date: 2012-01-24

Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-02-21
    End date: 2012-02-21

Erbitux
    Dosage: 600 mg, 1x/day
    Indication: Colon Cancer
    Start date: 2012-01-17
    End date: 2012-01-17

Irinotecan Hydrochloride
    Dosage: 200 mg, 1x/day
    Start date: 2012-02-14
    End date: 2012-02-14

Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-02-07
    End date: 2012-02-07

Irinotecan Hydrochloride
    Dosage: 200 mg, 1x/day
    Start date: 2012-01-31
    End date: 2012-01-31

Irinotecan Hydrochloride
    Dosage: 200 mg, 1x/day
    Indication: Colon Cancer
    Start date: 2012-01-17
    End date: 2012-01-17

Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-01-31
    End date: 2012-01-31

Erbitux
    Dosage: 400 mg, 1x/day
    Start date: 2012-02-14
    End date: 2012-02-14

Other drugs received by patient: Famotidine; Globulin N; Esomeprazole Magnesium; Platelets, Human Blood; Decadron; Clarithromycin; Amoxicillin; Promacta; Prednisolone



Possible Erbitux side effects in 62 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-16

Patient: 62 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Platelet Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 600mg,17-17jan12;250mg 1feb12-21feb12
    Indication: Colon Cancer
    Start date: 2012-01-17
    End date: 2012-02-21

Irinotecan HCL
    Dosage: on 14feb2012 taken with erbiux
    Indication: Colon Cancer
    Start date: 2012-01-17
    End date: 2012-02-14

Other drugs received by patient: Decadron; Famotidine



Possible Erbitux side effects in 60 year old female

Reported by a physician from United Kingdom on 2012-07-12

Patient: 60 year old female, weighing 61.0 kg (134.2 pounds)

Reactions: Dermatitis Acneiform, Intestinal Ischaemia, Intestinal Perforation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: route: also iv drip
    Indication: Colorectal Cancer Metastatic
    Start date: 2005-11-16
    End date: 2006-03-16

Irinotecan HCL
    Dosage: route: also iv drip
    Indication: Colorectal Cancer Metastatic
    Start date: 2005-11-16
    End date: 2006-03-16



Possible Erbitux side effects in 60 year old female

Reported by a physician from Germany on 2012-07-03

Patient: 60 year old female

Reactions: Dermatitis Acneiform, Intestinal Perforation

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Erbitux
    Indication: Colorectal Cancer Metastatic
    Start date: 2005-11-16
    End date: 2006-03-16

Irinotecan HCL
    Indication: Colorectal Cancer Metastatic
    Start date: 2005-11-16
    End date: 2006-03-16



Possible Erbitux side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-03

Patient: 60 year old female

Reactions: Intestinal Ischaemia, Dermatitis Acneiform, Intestinal Perforation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Indication: Colorectal Cancer Metastatic
    Start date: 2005-11-16
    End date: 2006-03-16

Irinotecan HCL
    Indication: Colorectal Cancer Metastatic
    Start date: 2005-11-16
    End date: 2006-03-16



Possible Erbitux side effects in 69 year old male

Reported by a physician from Japan on 2012-06-27

Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)

Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Fluorouracil
    Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02

Erbitux
    Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-03-05

Leucovorin Calcium
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02



Possible Erbitux side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Coma, Microcytic Anaemia, Anaemia Macrocytic, Multi-Organ Failure, Coombs Positive Haemolytic Anaemia, Aplasia Pure RED Cell, Thrombocytopenia, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Levoleucovorin Calcium
    Dosage: 300 mg/m2 for 4 days,every 15 days
    Start date: 2008-03-20
    End date: 2008-10-09

Levoleucovorin Calcium
    Dosage: 400 mg/m2 for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-05-05
    End date: 2007-08-01

Fluorouracil
    Dosage: 1000 mg/m2 for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-05-05
    End date: 2007-08-01

Irinotecan HCL
    Dosage: unspecified dose for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2008-09-04
    End date: 2008-10-09

Eloxatin
    Dosage: 25 mg/m2 for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-05-05
    End date: 2007-08-01

Fluorouracil
    Dosage: 1000 mg/m2 for 4 days,every 15 days
    Start date: 2008-01-21
    End date: 2008-01-01

Eloxatin
    Dosage: 25 mg/m2 for 4 days,every 15 days
    Start date: 2008-01-21
    End date: 2008-01-01

Fluorouracil
    Dosage: 800 mg/m2 for 4 days,every 15 days
    Start date: 2008-03-20
    End date: 2008-10-09

Emend
    Dosage: unspecified dose for 4 days,every 15 days
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2008-09-04
    End date: 2008-10-09

Levoleucovorin Calcium
    Dosage: 400 mg/m2 for 4 days,every 15 days
    Start date: 2008-01-21
    End date: 2008-01-01

Eloxatin
    Dosage: 20 mg/m2; frequency unspecified
    Start date: 2008-03-20
    End date: 2008-10-09

Erbitux
    Dosage: 500 mg/m2 for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-08-01
    End date: 2007-01-01

Erbitux
    Dosage: 500 mg/m2 for 4 days,every 15 days
    Start date: 2008-01-21
    End date: 2008-01-01

Erbitux
    Dosage: 500 mg/m2 for 4 days,every 15 days
    Start date: 2008-03-20
    End date: 2008-10-09



Possible Erbitux side effects in 69 year old male

Reported by a consumer/non-health professional from Japan on 2012-06-08

Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)

Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Leucovorin Calcium
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02

Erbitux
    Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-03-05

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02

Fluorouracil
    Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02



Possible Erbitux side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-06-06

Patient: 67 year old male

Reactions: Aphasia, Fall, Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 60 year old male

Reported by a consumer/non-health professional from United States on 2012-06-01

Patient: 60 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Haemorrhage, Rash Pruritic

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 34 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29

Patient: 34 year old male, weighing 72.0 kg (158.4 pounds)

Reactions: Coma, Microcytic Anaemia, Anaemia Macrocytic, Multi-Organ Failure, Coombs Positive Haemolytic Anaemia, Aplasia Pure RED Cell, Thrombocytopenia, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Levoleucovorin Calcium
    Dosage: 400 mg/m2 for 4 days,every 15 days
    Start date: 2008-01-21
    End date: 2008-01-01

Fluorouracil
    Dosage: 800 mg/m2 for 4 days,every 15 days
    Start date: 2008-03-20
    End date: 2008-10-09

Eloxatin
    Dosage: 25 mg/m2 for 4 days,every 15 days
    Start date: 2008-01-21
    End date: 2008-01-01

Erbitux
    Dosage: 500 mg/m2 for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-08-01
    End date: 2007-01-01

Erbitux
    Dosage: 500 mg/m2 for 4 days,every 15 days
    Start date: 2008-01-21
    End date: 2008-01-01

Levoleucovorin Calcium
    Dosage: 300 mg/m2 for 4 days,every 15 days
    Start date: 2008-03-20
    End date: 2008-10-09

Fluorouracil
    Dosage: 1000 mg/m2 for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-05-05
    End date: 2007-08-01

Irinotecan HCL
    Dosage: unspecified dose for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2008-09-04
    End date: 2008-10-09

Eloxatin
    Dosage: 25 mg/m2 for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-05-05
    End date: 2007-08-01

Erbitux
    Dosage: 500 mg/m2 for 4 days,every 15 days
    Start date: 2008-03-20
    End date: 2008-10-09

Emend
    Dosage: unspecified dose for 4 days,every 15 days
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2008-09-04
    End date: 2008-10-09

Levoleucovorin Calcium
    Dosage: 400 mg/m2 for 4 days,every 15 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-05-05
    End date: 2007-08-01

Fluorouracil
    Dosage: 1000 mg/m2 for 4 days,every 15 days
    Start date: 2008-01-21
    End date: 2008-01-01

Eloxatin
    Dosage: 20 mg/m2; frequency unspecified
    Start date: 2008-03-20
    End date: 2008-10-09



Possible Erbitux side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22

Patient: male, weighing 66.2 kg (145.7 pounds)

Reactions: Dyspnoea, Unresponsive To Stimuli, Snoring, Pulse Absent

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Erbitux
    Dosage: 700mg iv
    Indication: Head and Neck Cancer

Erbitux



Possible Erbitux side effects in 73 year old male

Reported by a consumer/non-health professional from Germany on 2012-04-26

Patient: 73 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Stomatitis, Neuropathy Peripheral, Interstitial Lung Disease, Skin Disorder

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: also 380mg from 10mar-1sep11.
    Indication: Rectosigmoid Cancer
    Start date: 2011-03-10
    End date: 2011-09-01

Oxaliplatin
    Dosage: also iv drip 100 , 10mar-1sep11.
    Indication: Rectosigmoid Cancer
    Start date: 2011-03-10
    End date: 2011-09-01

Other drugs received by patient: Isovorin; Leucovorin Calcium; Fluorouracil



Possible Erbitux side effects in 55 year old female

Reported by a consumer/non-health professional from Germany on 2012-04-26

Patient: 55 year old female

Reactions: Gastric Ulcer Haemorrhage, Anaemia, Melaena

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 1 df: 1 injection
    Indication: Tonsil Cancer
    Start date: 2012-02-09
    End date: 2012-02-09

Zantac
    Dosage: injection
    Indication: Premedication
    Start date: 2012-02-16
    End date: 2012-02-16

Zofran
    Dosage: 1 df: 1 injection
    Start date: 2012-02-09
    End date: 2012-02-09

Dexamethasone Sodium Phosphate
    Dosage: injection
    Indication: Tonsil Cancer
    Start date: 2012-02-16
    End date: 2012-02-16

Polaramine
    Dosage: injection
    Indication: Premedication
    Start date: 2012-02-16
    End date: 2012-02-16

Erbitux
    Dosage: injection
    Indication: Tonsil Cancer
    Start date: 2012-02-16
    End date: 2012-02-16

Other drugs received by patient: Acetaminophen



Possible Erbitux side effects in female

Reported by a physician from France on 2012-04-24

Patient: female

Reactions: Gastric Ulcer Haemorrhage, Anaemia, Melaena

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Dosage: 20mg cyclic
    Indication: Premedication
    Start date: 2012-02-16
    End date: 2012-02-16

Zofran
    Dosage: 8mg cyclic
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-09
    End date: 2012-02-09

Polaramine
    Dosage: 5mg cyclic
    Indication: Premedication
    Start date: 2012-02-16
    End date: 2012-02-16

Erbitux
    Dosage: 250mgm2 cyclic
    Indication: Tonsil Cancer
    Start date: 2012-02-16
    End date: 2012-02-16

Zantac
    Dosage: 50mg cyclic
    Indication: Premedication
    Start date: 2012-02-16
    End date: 2012-02-16

Carboplatin
    Indication: Tonsil Cancer
    Start date: 2012-02-09
    End date: 2012-02-09

Other drugs received by patient: Acetaminophen



Possible Erbitux side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-23

Patient: 73 year old male, weighing 81.0 kg (178.2 pounds)

Reactions: Fatigue, Dyspnoea, Embolism, Abdominal Pain Upper, Cough

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Taxol
    Dosage: paclitaxel 200mg/m2 days 71 and 92
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-04-05
    End date: 2010-04-05

Erbitux
    Dosage: cetuximab 250 mg/m2 days 50,57,64,71,78, 85,92,99,106
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-04-12
    End date: 2010-04-12

Carboplatin
    Dosage: carboplatin auc=6 days 71 and 92
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-04-05
    End date: 2010-04-05



Possible Erbitux side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-23

Patient: 59 year old male

Reactions: Diverticular Perforation, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 80 mg/m2 iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-11-30

Cisplatin
    Dosage: 80 mg/m2 unk iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14

Erbitux
    Dosage: 400 mg/m2 iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-11-30

Vinorelbin INN (Vinorelbine Tartrate) Solution FOR Injection. Mfr: NOT
    Dosage: 25 mg/m2 iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-12-05

Other drugs received by patient: Magnesium; Ativan; Prochlorperazine; Glaxal Base; Uremol



Possible Erbitux side effects in male

Reported by a physician from Japan on 2012-04-20

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Jaundice, Bile Duct Stenosis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Irinotecan Hydrochloride
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer Recurrent
    Start date: 2009-12-15
    End date: 2010-10-13

Oxaliplatin
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent
    Start date: 2009-12-15

Erbitux
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent

Other drugs received by patient: Novorapid; Lantus; Pydoxal



Possible Erbitux side effects in 49 year old male

Reported by a consumer/non-health professional from United States on 2012-04-17

Patient: 49 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Syncope, Pneumonia Aspiration, Asterixis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 1st dose 400mg/m2 then wk 250mg/m2 on day 1 cycle 1. on 2mar11:1day-ong-unk recent inf:20apr2011
    Indication: Head and Neck Cancer
    Start date: 2011-03-02

Alimta
    Dosage: last dose on 13apr11.
    Indication: Head and Neck Cancer
    Start date: 2011-03-02

Cisplatin
    Dosage: recent inf:13apr2011
    Indication: Head and Neck Cancer
    Start date: 2011-03-02

Other drugs received by patient: Lamotrgine; Lyrica; Fentanyl; Folic Acid; Lactulose; Vitamin B-12; Pantoprazole; Morphine; Dexamethasone



Possible Erbitux side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-09

Patient: 59 year old male

Reactions: Diverticular Perforation, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: interrupted on 30nov11 last dose:30nov11 4 courses
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-12-05

Erbitux
    Dosage: 14sep-14sep11,400mg/m2 05oct-30nov11,250mg/m2 last dose:30nov11 delay 5-19dec11 restart19dec11
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14

Cisplatin
    Dosage: interrupted on 30nov11 last dose:30nov11 4 courses 80mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-12-05

Other drugs received by patient: Uremol; Magnesium; Uremol; Prochlorperazine; Ativan; Glaxal Base



Possible Erbitux side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-09

Patient: 59 year old male

Reactions: Diverticular Perforation, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 400 mg/m2 iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-11-30

Cisplatin
    Dosage: 80 mg/m2 iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14

Vinorelbine
    Dosage: 25 mg/m2 iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-12-05

Erbitux
    Dosage: 80 mg/m2 iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-11-30

Other drugs received by patient: Prochlorperazine; Glaxal Base; Ativan; Uremol; Magnesium



Possible Erbitux side effects in 62 year old male

Reported by a consumer/non-health professional from Germany on 2012-03-30

Patient: 62 year old male, weighing 51.0 kg (112.2 pounds)

Reactions: Platelet Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 600mg,17-17jan12;400mg -21feb12
    Indication: Colon Cancer
    Start date: 2012-01-17
    End date: 2012-02-21

Irinotecan HCL
    Dosage: on 14feb2012 taken with erbiux
    Indication: Colon Cancer
    Start date: 2012-01-17
    End date: 2012-02-14

Other drugs received by patient: Decadron; Famotidine



Possible Erbitux side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-03-26

Patient: 59 year old male

Reactions: Diverticular Perforation, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: interrupted on 30nov11 last dose:30nov11 4 courses 80mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-12-05

Erbitux
    Dosage: 14sep-14sep11,400mg/m2 05oct-30nov11,250mg/m2 last dose:30nov11 delay 5-19dec11 restart19dec11
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14

Vinorelbine
    Dosage: interrupted on 30nov11 last dose:30nov11 4 courses
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-14
    End date: 2011-12-05

Other drugs received by patient: Glaxal Base; Ativan; Magnesium; Uremol; Uremol; Prochlorperazine



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014